ARCHIVES

NCI Cancer Studies In China Intact; Visits Delayed

This article is from The Cancer Letter archive.

Vol. 15 No. 28 | July 14, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

NCI Awards $15M For Studies Of Glycobiology.

September 28, 2007

Program Announcements

July 25, 1986